Clinical Trials Logo

Clinical Trial Summary

The following pilot study will be undertaken to determine the effects of use of a zero-sodium peritoneal dialysate solution (10% dextrose in sterile water) on sodium removal as compared to a standard peritoneal dialysis solution.


Clinical Trial Description

While heart failure (HF) is generally regarded as the inability of the heart to pump sufficient blood, on a population level, volume overload is the primary driver of morbidity and hospitalization. The signs and symptoms of volume overload are driven by water accumulation, which is initially driven by sodium retention. This overall goal of this study is to investigate the ability to remove sodium through use of a zero-sodium solution in peritoneal dialysis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03801226
Study type Interventional
Source Yale University
Contact Devin D Mahoney
Phone 203-737-6227
Email devin.mahoney@yale.edu
Status Recruiting
Phase Early Phase 1
Start date December 1, 2018
Completion date December 31, 2020

See also
  Status Clinical Trial Phase
Recruiting NCT03505788 - Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR) Phase 4
Recruiting NCT01617798 - Stop Hypernatremia, Use Metolazone, for Aggressive, Controlled, Effective Diuresis N/A
Recruiting NCT03194750 - Ultrasound Assessment of Volume in Patients on Continuous Dialysis N/A
Completed NCT03168126 - Advanced Hemodynamic Monitoring in Free Flap Surgery N/A
Recruiting NCT02769351 - Global rEgistry on decongestioN Therapy Using Less invasivE UltraFiltration
Completed NCT03755843 - PREDICTION OF FLUID RESPONSIVENESS WITH PASSIVE LEG RISING IN PREGNANT PATIENTS WITH SEVERE PREECLAMPSIA